Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in GALT — Galectin Therapeutics Inc

CIK 19617 NEW YORK, NY
Back to GALT Full portfolio

Position in GALT

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$172,550
+$141,741 QoQ
Shares Held
37,188
+236.8% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 98 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 12% Shared 0% None 88%

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,196,194 across 425 Biotechnology names. GALT ranks #241 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in GALT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $172,550 37,188
2026-03-31 $30,809 11,043
2025-12-31 $45,938 11,043
2025-09-30 $65,591 15,470
2025-06-30 $26,030 12,337
2025-03-31 $20,696 16,965
2024-12-31 $77,002 59,693
2024-09-30 $84,226 30,628
2024-06-30 $26,489 11,721
2024-03-31 $4,470 1,871
2023-12-31 $3,025 1,823
2023-09-30 $178 93
2023-06-30 $61 43
2023-03-31 $90 43
2022-12-31 $48 43
2022-09-30 $70 43
2022-06-30 $56 43
2022-03-31 $69 43
2021-12-31 $89 43
2021-09-30 $166 43
2021-06-30 $137 43
2021-03-31 $218,203 100,555
2020-12-31 $232,317 103,713
2020-09-30 $57,869 21,674
2020-06-30 $85,713 28,011
2020-03-31 $79,573 40,599